mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.004 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.005 |